eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | blepharospasm |
| Comorbidity | C0013421|dystonia |
| Sentences | 5 |
| PubMedID- 25992183 | The food and drug administration first approved botulinum toxin (bt) type a in 1989 for the treatment of strabismus and blepharospasm associated with dystonia in patients 12 years of age or older. |
| PubMedID- 24131497 | Exclusion criteria were as follows: presence of any multifocal dystonia with blepharospasm or oromandibular manifestations, a positive family history for dystonia and a history of any other neurological disease or relevant vascular diseases. |
| PubMedID- 25764999 | The spread of dystonia in patients with the initial blepharospasm was faster, while patients with the writer's cramp could expect further progression even after longer periods of time. |
| PubMedID- 20507022 | Orbicularis oculi myo-osseous fixation: a new treatment for benign essential blepharospasm and blepharospasm associated with diffuse facial dystonia (meige syndrome). |
| PubMedID- 20616916 | Meige syndrome is a cranial dystonia with bilateral blepharospasm accompanied by dystonia in the lower face. |
Page: 1